SGTi-flex COVID-19 Ag
SGTi-flex COVID-19 Ag is a rapid antigen diagnosis kit that can be visually confirmed by detecting SARS-CoV-2 specific antigens .
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- D/A,D/P,L/C,T/T
- Production method
- Available
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- ppe, detection kit, covid19
- Category
- Medical Devices
Caremile Inc
South Korea
- Verified Certificate
-
4
| Product name | SGTi-flex COVID-19 Ag | Certification | CE |
|---|---|---|---|
| Category | Medical Devices | Material | - |
| Keyword | ppe , detection kit , covid19 | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | 100000 |
| Supply type | Available | HS code | - |
Product Information
SGTi-flex COVID-19 Ag is a rapid antigen diagnosis kit that can be visually confirmed by detecting SARS-CoV-2 specific antigens with human nasal samples.
The main selling points of antigen tests are that they are far faster and easier to perform than reverse transcriptase-polymerase chain reaction (PCR) tests. PCR tests – the swab tests that look for viral RNA – are currently the most common way to test for an active SARS-CoV-2 infection and can take up to four days to perform.
By contrast, the most time-consuming part of the antigen test process is waiting for the antibody mixtures and the sample to mix completely. This process takes mere minutes, given the small volumes typically used in an antigen test. A COVID-19 antigen test might take only 15-30 minutes to complete and requires very little expertise. Similar tests are done routinely in clinics for influenza all the time. In contrast, PCR tests swabs must be sent to diagnostic laboratories to be performed by experienced technicians as of right now.
SGTi-flex COVID-19 Ag is a rapid antigen diagnosis kit that can be visually confirmed by detecting SARS-CoV-2 specific antigens with human nasal samples.
The main selling points of antigen tests are that they are far faster and easier to perform than reverse transcriptase-polymerase chain reaction (PCR) tests. PCR tests – the swab tests that look for viral RNA – are currently the most common way to test for an active SARS-CoV-2 infection and can take up to four days to perform.
By contrast, the most time-consuming part of the antigen test process is waiting for the antibody mixtures and the sample to mix completely. This process takes mere minutes, given the small volumes typically used in an antigen test. A COVID-19 antigen test might take only 15-30 minutes to complete and requires very little expertise. Similar tests are done routinely in clinics for influenza all the time. In contrast, PCR tests swabs must be sent to diagnostic laboratories to be performed by experienced technicians as of right now.
- Verified Certificate
-
B2B Trade
| Price (FOB) | Negotiable | transportation | Air Transportation,Negotiation Other,Ocean Shipping |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | D/A,D/P,L/C,T/T | Shipping time | Negotiable |
Caremile Inc
-
4
- President
- Danny yoo
- Address
- 5F, Famoso B/D, 427, Dosan-daero 427, Gangnam-gu, Seoul, Korea
- Product Category
- Other Monitoring & Diagnostic Equipment
- Year Established
- 2017
- No. of Total Employees
- 1-50
- Company introduction
-
Caremile was established as a cosmetics manufacturer in 2017 and has been selling in Korea and exporting to Hong Kong and China. It was acquired by Alpha Group in October 2019 and exports Korean COVID-19 diagnostic kits, PPE, and quarantine products to more than 50 countries through Alpha Group's overseas trade and marketing network. From the second half of 2020, it has launched and sold K-quarantine products (protective clothing, quarantine gate, access, disinfection sterilizer, etc.).
We have established a healthcare-specific distribution platform with domestic and foreign distribution partners and manufacturers, distributing K-quarantine products and medical devices to domestic and foreign markets, and are gradually expanding the scope of supplier value creation beyond the two-sided market using B2B and B2C distribution platforms.
By expanding the scope and size of the business, we intend to break down the scope and boundaries beyond the existing areas to expand the platform format and build an ecosystem that allows various participation in digital networks to become a total lifecare service value changer for both domestic and global markets.
- Main Product
- Attached File
Related Products
Modular type ENT workstation_XU5 Visual
Covid 19 Detection
PRF BOX Implant
Stryker 1088 HD Camera Control
Implant system (SLA surface)
